Skip to main content

Polycystic Ovary Syndrome

Unveiling the shared genetic architecture between testosterone and polycystic ovary syndrome


Testosterone (T) is a critical predictor of polycystic ovary syndrome (PCOS) but the genetic overlap between T and PCOS has not been established. Here by leveraging genetic datasets from large-scale genome-wide association studies, we assessed the genetic correlation and polygenic overlap between PCOS and three T-related traits using linkage disequilibrium score regression and the bivariate causal mixture model methods.

The conjunctional false discovery rate (conjFDR) method was employed to identify shared causal variants. Functional annotation of variants was conducted using FUMA. Total T and bioavailable T exhibited positive correlations with PCOS, while sex hormone-binding globulin (SHBG) showed a negative correlation. All three traits demonstrated extensive genetic overlap with PCOS, with a minimum of 68% of T-related variants influencing PCOS.

The conjFDR revealed 4 to 6 causal variants within joint genomic loci shared between PCOS and T-related traits. Functional annotations suggested that these variants might impact PCOS by modulating nearby genes, such as FSHB. Our findings support the hypothesis that PCOS is significantly influenced by androgen abnormalities. Additionally, this study identified several causal variants potentially involved in shared biological mechanisms between PCOS and T regulation.

Polycystic ovary syndrome (PCOS) stands out as one of the most prevalent endocrine abnormalities, affecting 6–20% of women globally within their reproductive years. The presentation of PCOS is notably intricate and heterogeneous, with clinical diagnosis primarily relying on three key characteristics: the presence of clinical or biochemical hyperandrogenism (HA), chronic ovulatory dysfunction (OD), and ultrasound-indicated polycystic ovarian morphology (PCOM).

The 1990 US National Institutes of Health (NIH) criteria initially defined PCOS as the presence of both HA and OD, while the 2003 Rotterdam criteria expanded this definition to include the diagnosis of PCOM, requiring the presence of at least two of the three characteristics. Subsequently, mounting evidence suggested that HA might involve in major pathophysiological mechanisms underlying PCOS, leading the 2006 Androgen Excess and PCOS Society (AE-PCOS) Position Statement to assert that PCOS should primarily be considered a disorder of androgen excess or HA.

Polycystic ovary syndrome, hormonal imbalance, insulin resistance, irregular periods, ovarian cysts, infertility, acne, hirsutism, weight gain, mood swings, menstrual disorders, metabolic syndrome, reproductive health, anovulation, androgen excess, endocrine disorder, hair thinning, chronic inflammation, type 2 diabetes, lifestyle management

#PCOS, #PolycysticOvarySyndrome, #HormonalImbalance, #WomensHealth, #IrregularPeriods, #FertilityAwareness, #OvarianCysts, #EndocrineDisorder, #PCOSAwareness, #AcneProblems, #Hirsutism, #MetabolicSyndrome, #InsulinResistance, #HairThinning, #HealthyHormones, #PCOSSupport, #Anovulation, #Type2DiabetesRisk, #WeightGainStruggles, #WomensWellness

International Conference on Genetics and Genomics of Diseases

Visit: genetics-conferences.healthcarek.com

Award Nomination: genetics-conferences.healthcarek.com/award-nomination/?ecategory=Awards&rcategory=Awardee

Award registration: genetics-conferences.healthcarek.com/award-registration/

For Enquiries: contact@healthcarek.com

Get Connected Here
---------------------------------
---------------------------------
in.pinterest.com/Dorita0211
twitter.com/Dorita_02_11_
facebook.com/profile.php?id=61555903296992
instagram.com/p/C4ukfcOsK36
genetics-awards.blogspot.com/
youtube.com/@GeneticsHealthcare

    Comments

    Post a Comment

    Popular posts from this blog

    Genetic factors with clinical trial stoppage

    Genetic factors associated with reasons for clinical trial stoppage Many drug discovery projects are started but few progress fully through clinical trials to approval. Previous work has shown that human genetics support for the therapeutic hypothesis increases the chance of trial progression. Here, we applied natural language processing to classify the free-text reasons for 28,561 clinical trials that stopped before their endpoints were met. We then evaluated these classes in light of the underlying evidence for the therapeutic hypothesis and target properties. We found that trials are more likely to stop because of a lack of efficacy in the absence of strong genetic evidence from human populations or genetically modified animal models. Furthermore, certain trials are more likely to stop for safety reasons if the drug target gene is highly constrained in human populations and if the gene is broadly expressed across tissues. These results support the growing use of human genetics to ...
    Post a Comment
    Read more

    Type of Inherited Blindness in Dogs

    Genetic test could eradicate a type of inherited blindness in dogs A mountain rescue dog whose duties ended after her eyesight failed has helped scientists create a test that could eradicate the genetic eye condition in her breed for good. Shola the English shepherd has an inherited eye disease called progressive retinal atrophy (PRA) that causes the light-sensitive cells at the back of the eye to deteriorate, eventually leading to blindness. PRA affects more than 100 dog breeds, can be caused by a number of different genetic variants and has no treatment. For some types, symptoms do not appear until the dog is several years old , by which point they may have passed their genes on to puppies. Katherine Stanbury, the first author of the research from the University of Cambridge, said Shola was four years old when she began struggling with her vision in dim light. “She was sent to a veterinary ophthalmologist and they confirmed that she had PRA,” said Stanbury. “And then it turned out h...
    Post a Comment
    Read more

    Post-Stroke Cardiovascular risks

    Study finds genetic factors key to post-stroke cardiovascular risks In a recent study published in the journal Stroke , researchers identify genetic and molecular risk factors for subsequent cardiovascular outcomes after incident stroke in an effort to identify potential therapeutic targets to improve patient prognoses. Identifying the causes of stroke Stroke is a major global health issue that causes significant disability and mortality, particularly arterial ischemic stroke (AIS). AIS, which is a type of stroke caused by blocked blood flow to the brain, is responsible for up to 85% of stroke cases. AIS arises due to cerebral blood vessel blockage, with modifiable risk factors including hypertension, diabetes, dyslipidemia, atrial fibrillation, obesity, and lifestyle behaviors. Although genome-wide association studies (GWAS) often focus on incident strokes, studying subsequent events can provide new insights into stroke progression. Further research is crucial to identify genetic and...
    Post a Comment
    Read more